CN Stock MarketDetailed Quotes
688319 Chengdu Olymvax Biopharmaceuticals Inc
- 10.16
- -0.41-3.88%
Trading Nov 18 14:25 CST
4.12BMarket Cap-483809P/E (TTM)
10.61High10.05Low31.50KlotVolume10.57Open10.57Pre Close32.30MTurnover0.78%Turnover Ratio236.28P/E (Static)405.93MShares20.5152wk High4.53P/B4.12BFloat Cap7.0252wk Low12.68Limit Up405.41MShs Float48.62Historical High8.46Limit Down5.30%Amplitude7.02Historical Low0.04Dividend TTM10.25Avg Price20.69KlotAsk0.37%Div YieldTTM100Lot Size9.69KlotBid
Chengdu Olymvax Biopharmaceuticals Inc Key Stats
EPS
According to the latest financial report of Chengdu Olymvax Biopharmaceuticals Inc, the latest earnings per share (TTM) for the company is 0.01. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Chengdu Olymvax Biopharmaceuticals Inc's latest financial report to see how much their book value per share (BVPS) is currently at 2.24.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Chengdu Olymvax Biopharmaceuticals Inc shows that the company's current ratio is 1.86, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Chengdu Olymvax Biopharmaceuticals Inc, the quick ratio is 1.67, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Chengdu Olymvax Biopharmaceuticals Inc? The latest ROE figure is 0.44%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Chengdu Olymvax Biopharmaceuticals Inc, the total asset return on investment (ROA) is -0.01%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Chengdu Olymvax Biopharmaceuticals Inc's latest financial report to see how their gross margin is doing - currently at 94.72%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Chengdu Olymvax Biopharmaceuticals Inc, the net profit margin is -0.02%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data